Continuing Education
Purpose/Objective
At the conclusion of this program, learners will share that they feel better prepared to manage patients presenting with headache conditions by applying best practices in Headache Medicine related to diagnosis, epidemiology, and treatment of headache disorders in adults and children in clinical practice and research, apply cutting-edge approaches to the assessment of outcomes in clinical practice, develop strategies for the treatment of refractory headaches and headaches during pregnancy, and incorporate processes to comply with new documentation requirements and enhance employee retention.
Accreditation Statement
The American Headache Society® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
The American Headache Society® designates this Other activity (live and recorded sessions) for a maximum of 42.50AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABPN
THE AMERICAN BOARD OF PSYCHIATRY AND NEUROLOGY HAS REVIEWED THE 2023 SCOTTSDALE HEADACHE SYMPOSIUM AND HAS APPROVED THIS ACTIVITY AS PART OF A COMPREHENSIVE SELF-ASSESSMENT (SA) CME ACTIVITY, WHICH IS MANDATED BY THE ABMS AS A NECESSARY COMPONENT OF CONTINUING CERTIFICATION.
This activity awards up to 42.5 Category 1 CME credits as Self-Assessment CME credits. The approval period is for November 16 – 19, 2023. SA activity available until 5/20/2024.
AAFP
The AAFP has reviewed 2023 Scottsdale Headache Symposium and deemed it acceptable for up to 22.75 Live AAFP Elective credits. Term of Approval is from 11/16/2023 to 11/19/2023. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Instructions for Claiming CME
- Go to Education On Demand (all attendees, including AHS members, should create a visitor account or log in with the visitor credentials created during the Annual Scientific Meeting).
- Please be sure to use the same email address that you used during registration for the Symposium
- Once logged in, you will see the sessions listed on the left-hand side. Click on any session you wish to view.
- Complete the post-activity evaluation here. We suggest you wait to complete the evaluation/claim credit until you’ve watched all recorded sessions for which credit* is sought. The recorded sessions will be available until Monday, May 20, 2024 and the evaluation will be available until Monday, June 17, 2024.
- For ABPN Self-Assessment Credit, complete the short ABPN Self-Assessment Quiz
- Enter the number of CME credits being claimed per credit type
- Download your certificate (be sure to select AMA credit [MD/DOs] or Participation credit [all others] to access a certificate)
*Please note: The maximum number of credits is calculated based on attending all live and watching all recorded concurrent sessions. Some CME sessions are only offered live and will not be recorded.
Financial Disclosures
The planners and faculty for this activity did not have any relationships to disclose unless listed here. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.
Disclosure of Commercial Support
The American Headache Society received funding for this activity from the following organizations:
AbbVie, Inc
Eli Lilly and Company
Lundbeck Pharmaceuticals, LLC
Pfizer Inc.
The American Headache Society received an in-kind donation of migraine units (heads) for Concurrent Session 1: Injection Training from the following organizations:
AbbVie, Inc.